medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2012, Número 1

<< Anterior

Rev Invest Clin 2012; 64 (1)


Alteraciones visuales asociadas al tabaquismo. Una revisión sistemática a propósito de un caso clínico

Sansores RH, Ramírez-Venegas A, Pérez-Bautista Ó, Bustos M

Idioma: Español
Referencias bibliográficas: 77
Paginas: 89-101
Archivo PDF: 200.84 Kb.


FRAGMENTO

INTRODUCCIÓN
El tabaquismo está asociado a un número importante de enfermedades crónicas que llevan a incapacidad física, serio deterioro de la calidad de vida y, eventualmente, muerte prematura.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ezzati M, López AD. Estimates of global mortality attributable to smoking in 2000.Lancet 2003; 362: 847-52.

  2. Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. N Engl J Med 2008; 358: 2606-17.

  3. Stan MN, Bahn RS. Risk factors for development or deterioration of Grave´s ophthalmopathy. Thyroid 2010; 20: 777-83.

  4. Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP. Smoking and age-related macular degeneration: a review of association. Eye 2005; 19: 935-44.

  5. Neuner B, Komm A, Wellmann J, Dietzel M, Pauleikhoff D, Walter J, et al. Smoking history and the incidence of age-related macular degeneration-results from the Muenster Aging and Retina Study (MARS) cohort and systematic review and metaanalysis of observational longitudinal studies. Addict Behav 2009; 34: 938-47.

  6. Despriet DD, Van Duijn CM, Oostra BA, Uitterlinden AG, Hofman A, Wright AF, et al. Complement component C3 and risk of age-related macular degeneration. Ophthalmology 2009; 116: 474-80.

  7. Cong R, Zhou B, Sun Q, Gu H, Tang N, Wang B. Smoking and the risk of age-related macular degeneration: a metaanalysis. Ann Epidemiol 2008; 18: 647-56.

  8. Bauer P, Barthelmes D, Kurz M, Fleischhauer JC, Sutter FK. The potential effect of population development, smoking and antioxidant supplementation on the future epidemiology of age-related macular degeneration in Switzerland. Klin Monbl Augenheilkd 2008; 225: 376-9.

  9. Chong EW, Kreis AJ, Wong TY, Simpson JA, Guymer RH. Alcohol consumption and the risk of age-related macular degeneration: a systematic review and meta-analysis. Am J Ophthalmol 2008; 145: 707-15.

  10. Conley YP, Jakobsdottir J, Mah T, Weeks DE, Klein R, Kuller L, Ferrell RE, Gorin MB. CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analyses. Hum Mol Genet 2006; 15: 3206-18.

  11. Bojanowski CM, Shen D, Chew EY, Ning B, Csaky KG, Green WR, et al. Anapolipoprotein E variant may protect against agerelated macular degeneration through cytokine regulation. Environ Mol Mutagen 2006; 47: 594-602.

  12. Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology 2001; 108: 697-704.

  13. Klein R, Klein BE, Knudtson MD, Meuer SM, Swift M, Gangnon RE. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 2007; 114: 253-62.

  14. Van Newkirk MR, Nanjan MB, Wang JJ, Mitchell P, Taylor HR, McCarty CA. The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology 2000; 107: 1593-600.

  15. Meyers SM. A twin study on age-related macular degeneration. Trans Am Ophthalmol Soc 1994; 92: 775-843.

  16. Meyers SM, Greene T, Gutman FA. A twin study of age-related macular degeneration. Am J Ophthalmol 1995; 120: 757-66.

  17. Seddon JM, Cote J, Page WF, Aggen SH, Neale MC. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 2005; 123: 321-7.

  18. Bressler SB, Muñoz B, Solomon SD, West SK; Salisbury Eye Evaluation (SEE) Study Team. Racial differences in the prevalence of age-related macular degeneration: the Salisbury Eye Evaluation (SEE) Project. Arch Ophthalmol 2008; 126: 241-5.

  19. Klein R, Klein BE, Knudtson MD, Wong TY, Cotch MF, Liu K, et al. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology 2006; 113: 373-80.

  20. Jampol LM, Tielsch J. Race, Macular degeneration, and the Macular Photocoagulation Study. Arch Ophthalmol 1992; 110: 1699-700.

  21. Seddon JM, Santangelo SL, Book K, Chong S, Cote JA. Genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am J Hum Genet 2003; 73: 780-90.

  22. Conley YP, Thalamuthu A, Jakobsdottir J, Weeks DE, Mah T, Ferrell RE, Gorin MB. Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. Hum Mol Genet 2005; 14: 1991-2002.

  23. Donoso LA, Kim D, Frost A, Callahan A, Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2006; 51: 137-52.

  24. Thakkinstian A, Han P, Mc Evoy M, Smith W, Hoh J, Magnusson K, et al. Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum Mol Genet 2006; 15: 2784-90.

  25. Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 2005; 77: 389-407.

  26. Leveziel N, Souied EH, Richard F, Barbu V, Zourdani A, Morineau G, et al. PLEKHA1-LOC387715-HTRA1 polymorphisms and exudative age-related macular degeneration in the French population. Mol Vis 2007; 13: 2153-9.

  27. Dowler S, Currie RA, Campbell DG, Deak M, Kular G, Downes CP, Alessi DR. Identification of pleckstrin-homology-domain- containing proteins with novel phosphoinositide-binding specificities. Biochem J 2000; 351: 19-31.

  28. Schmidt S, Hauser MA, Scott WK, Postel EA, Agarwal A, Gallins P, et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 2006; 78: 852-64.

  29. Khan JC, Thurlby DA, Shahid H, Clayton DG, Yates JR, Bradley M, et al. Genetic Factors in AMD Study. Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularization. Br J Ophthalmol 2006; 90: 75-80.

  30. Klein R, Knudtson MD, Cruickshanks KJ, Klein BE. Further observations on the association between smoking and the longterm incidence and progression of age-related macular degeneration: the Beaver Dam Eye Study. Arch Ophthalmol 2008; 126: 115-21.

  31. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, et al. Lack of effect of long-term supplementation with betacarotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145-9.

  32. Seddon JM, Christen WG, Manson JE, Buring JE, Sperduto RD, Hennekens CH. Low-dose aspirin and risks of cataract in a randomized trial of US physicians. Arch Ophthalmol 1991; 109: 252-5.

  33. Schaumberg DA, Christen WG, Hankinson SE, Glynn RJ. Body mass index and the incidence of visually significant agerelated maculopathy in men. Arch Ophthalmol 2001; 119: 1259-65.

  34. Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol 2003; 121: 785-92.

  35. Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 2002; 134: 411-31.

  36. Klein R, Klein BE, Tomany SC, Cruickshanks KJ. Of emphysema, gout, and inflammatory markers with long-term incidence of age-related maculopathy. Arch Ophthalmol 2003; 121: 674-8.

  37. Shankar A, Mitchell P, Rochtchina E, Tan J, Wang JJ. Association between circulating white blood cell count and long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Am J Epidemiol 2007; 165: 375-82.

  38. Seddon JM, Gensler G, Klein ML, Milton RC. C-reactive protein and homocysteine are associated with dietary and behavioral risk factors for age-related macular degeneration. Nutrition 2006; 22: 441-3.

  39. Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA 2004; 291: 704-10.

  40. Tuo J, Smith BC, Bojanowski CM, Meleth AD, Gery I, Csaky KG, et al. The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J 2004; 18: 1297-9.

  41. Ding X, Patel M, Chan CC. Molecular pathology of age-related macular degeneration. Prog Retin Eye Res 2009; 28: 1-18.

  42. SanGiovanni JP, Chew EY, Clemons TE, Davis MD, Ferris FL 3rd, Gensler GR, et al.; Age-Related Eye Disease Study Research Group. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol 2007; 125: 671-9.

  43. San Giovanni JP, Chew EY, Agrón E, Clemons TE, Ferris FL 3rd, Gensler G, et al.; Age-Related Eye Disease Study Research Group. The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch Ophthalmol 2008; 126: 1274-9.

  44. Chong EW, Robman LD, Simpson JA, Hodge AM, Aung KZ, Dolphin TK, et al. Fat consumption and its association with age-related macular degeneration. Arch Ophthalmol 2009; 127: 674-80.

  45. Chong EW, Kreis AJ, Wong TY, Simpson JA, Guymer RH. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol 2008; 126: 826-33.

  46. Pérez-Bautista O, Escobar-Arriaga E, Ramírez-Venegas, Sansores RH. Differences in inflammatory markers in a non-smoking and smoking Mexican population. Rev Invest Clin 2009; 61: 205-11.

  47. Lois N, Abdelkader E, Reglitz K. Enviromental tobacco smoke exposure and eye disease. Br J Ophthalmol 2008; 92: 1304-10.

  48. Shah SP, Dineen B, Jadoon Z, Bourne R, Khan MA, Johnson GJ, et al. Lens opacities in adults in Pakistan: prevalence and risk factors. Ophthalmic Epidemiol 2007; 14: 381-9.

  49. Nemet AY, Vinker S, Levartovsky S, Kaiserman I. Is cataract associated with cardiovascular morbidity. Eye 2010; 24: 1352-8.

  50. Lindblad BE, Håkansson N, Svensson H, Philipson B, Wolk A. Intensity of smoking and smoking cessation in relation to risk of cataract extraction: a prospective study of women. Am J Epidemiol 2005; 162: 73-9.

  51. Tan JS, Wang JJ, Younan C, Cumming RG, Rochtchina E, Mitchell P. Smoking and the long-term incidence of cataract: the Blue Mountains Eye Study. Ophthalmic Epidemiol 2008; 15: 155-6.

  52. Krishnaiah S, Vilas K, Shamanna BR, Rao GN, Thomas R, Balasubramanian D. Smoking and its association with cataract: results of the Andhra Pradesh eye disease study from India. Invest Ophthalmol Vis Sci 2005; 46: 58-65.

  53. Athanasiov PA, Edussuriya K, Senaratne T, Sennanayake S, Sullivan T, Selva D, Casson RJ. Cataract in central Sri Lanka: prevalence and risk factors from the Kandy Eye Study. Ophthalmic Epidemiol 2010; 17: 34-40.

  54. Athanasiov PA, Casson RJ, Sullivan T, Newland HS, Shein WK, Muecke JS, et al. Cataract in rural Myanmar: prevalence and risk factors from the Meiktila Eye Study. Br J Ophthalmol 2008; S92: 1169-74.

  55. Kelly SP, Thornton J, Edwards R, Sahu A, Harrison R. Smoking and cataract: review of causal association. J Cataract Refract Surg 2005; 31: 2395-404.

  56. Robman L, Taylor H. External Factors in the development of cataract. Eye 2005; 19: 1074-82.

  57. Kalariya NM, Nair B, Kalariya DK, Wills NK, van Kuijk FJ. Cadmium-induced induction of cell death in human lens epithelial cells: Implications to smoking associated Cataractogenesis. Toxicol Lett 2010; 198: 56-62.

  58. Mosad SM, Ghanem AA, El-Fallal HM, El-Kannishy AM, El Baiomy AA, Al-Diasty AM, Arafa LF. Lens cadmium, lead, and serum vitamins C, E, and beta carotene in cataractous smoking patients. Curr Eye Res 2010; 35: 23-30.

  59. Raju P, George R, Ve Ramesh S, Arvind H, Baskaran M, Vijaya L. Influence of tobacco use on cataract development. Br J Ophthalmol 2006; 90: 1374-7.

  60. Zanon-Moreno V, Garcia-Medina JJ, Zanon-Viguer V, Moreno- Nadal MA, Pinazo Duran MD. Smoking, an additional risk factor in elder women with primary open-angle glaucoma. Molecular Vision 2009; 15: 2953-59.

  61. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90: 262-7.

  62. Fechtner RD, Khouri AS. Evolving global risk assessment of ocular hypertension to glaucoma. Curr Opin Ophthalmol 2007; 18: 104-9.

  63. Cheng ACK, Pang CP, Leung ATS, Chua JKH, Fan DSP, Lam DSC The association between cigarette smoking and ocular diseases. HKMJ 2000; 6: 195-202.

  64. Bonovasa S, Filioussia K, Tsantesa A, Peponisb V. Epidemiological association between cigarette smoking and primary open-angle glaucoma: a meta-analysis. Public Health 2004; 118: 256-61.

  65. Edwars R, Thornton J, Ajit R, Harrison R, Kelly SP. Cigarette smoking and primary open angle glaucoma: A systematic review. J Glaucoma 2008; 17: 558-66.

  66. Fan BJ, Leung YF, Wang N, et al. Genetic and environmental risk factors for primary open-angle glaucoma. Chung Hua I Hsweh Tsa Chih 2004; 117: 706-10.

  67. Juronen E, Tasa G, Veromann S, et al. Polymorphic glutathione S-transferase M1 is a risk factor of primary openangle glaucoma among Estonians. Exp Eye Res 2000; 71: 447-52.

  68. Kaimbo DKW, Buntinx F, Missotten L. Risk factors for openangle glaucoma: a case-control study. J Clin Epidemiol 2001; 54: 166-71.

  69. Nemesure B, Wu SY, Hennis A, Leske MC. Factors related to the 4-year risk of high intraocular pressure the Barbados Eye Studies for the Barbados Eye Studies Group. Arch Ophthalmol 2003; 121: 856-62.

  70. Kang JH, Pasquale LR, Rosner BA, Willett WC, Egan KM, Faberowski N, Hankinson SE. Prospective study of cigarette. Smoking and the risk of primary open-angle glaucoma. Arch Ophthalmol 2003; 121: 1762-8.

  71. Doshi V, Ying-Lai M, Azen SP, Varma R; Los Angeles Latino Eye Study Group. Sociodemographic, family history, and lifestyle risk factors for open-angle glaucoma and ocular hypertension. The Angeles Latino Eye Study. Ophthalmology 2008; 115: 639-47.

  72. Co T, Niger R. The effects of cigarette smoking on intraocular Pressure and arterial blood Pressure of normotensive Young Nigerian male adults. J Physiol Sci 2007; 22: 33-6.

  73. Garrison GD, Dugan SE. Varenicline: a first-line treatment option for smoking cessation. Clin Ther 2009; 31: 463-91.

  74. McNeil JJ, Piccenna L, Loannides-Demos LL. Smoking cessation-recent advances. Cardiovasc Drugs Ther 2010; 24: 359-67.

  75. Urdapilleta-Herrera EC, Sansores R, Ramírez-Venegas A, et al. Ansiedad y depresión en fumadores mexicanos y su relación con el grado de adicción. Sal Púb Méx 2010; 52(Supl. 2): S120-S128.

  76. Gilbert-Lucido M, García-Huerta M, et al. Estudio epidemiológico de glaucoma en población mexicana. Rev Mex Oftalmol 2010; 84(2): 86-90.

  77. Barojas-Weber E, San Juan-Estrada E, Ortega-Larrocea G. Reporte de una campaña quirúrgica de catarata del Instituto Nacional de Salud. Rev Mex Oftalmol 2010; 84(2): 91-5.




2020     |     www.medigraphic.com